Drotrecogin alfa (activated) treatment of older patients with severe sepsis. (Q47765880)

5 February 2018

title

Drotrecogin alfa (activated) treatment of older patients with severe sepsis. (English)

1 reference

5 February 2018

1 reference

2

Derek C Angus

1 reference

5 February 2018

1

E Wesley Ely

1 reference

5 February 2018

Gordon R. Bernard

6

object named as

Gordon R Bernard

1 reference

5 February 2018

author name string

Mark D Williams

3

1 reference

5 February 2018

Becky Bates

4

1 reference

5 February 2018

Rebecca Qualy

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

8 July 2003

1 reference

5 February 2018

Clinical Infectious Diseases

published in

1 reference

5 February 2018

volume

37

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

187-195

1 reference

5 February 2018

Epidemiology of sepsis syndrome in 8 academic medical centers

cites work

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?

21 January 2018

1 reference

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

21 January 2018

1 reference

Mechanical ventilation in a cohort of elderly patients admitted to an intensive care unit.

21 January 2018

1 reference

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

21 January 2018

1 reference

Serial evaluation of the SOFA score to predict outcome in critically ill patients

21 January 2018

1 reference

Warfarin therapy for an octogenarian who has atrial fibrillation

21 January 2018

1 reference

Hospital costs in patients receiving prolonged mechanical ventilation: does age have an impact?

21 January 2018

1 reference

Intensive care unit use and mortality in the elderly

21 January 2018

1 reference

Thrombolytic therapy for eligible elderly patients with acute myocardial infarction

21 January 2018

1 reference

Influence of age on Medicare expenditures and medical care in the last year of life

21 January 2018

1 reference

Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging

21 January 2018

1 reference

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study

21 January 2018

1 reference

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials

21 January 2018

1 reference

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/375775

1 reference

5 February 2018

PubMed ID

12856210

1 reference

5 February 2018